XBIO
Xenetic Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.33M
P/E Ratio
—
EPS
$-1.19
Beta
2.22
52W High
$13.93
52W Low
$1.90
50-Day MA
$3.13
200-Day MA
$2.94
Dividend Yield
—
Profit Margin
-70.00%
Forward P/E
—
PEG Ratio
0.00
About Xenetic Biosciences Inc
Xenetic Biosciences, Inc., a biopharmaceutical company, is focused on advancing XCART, a customized chimeric antigen receptor T (CAR T) platform technology designed to target patient-specific tumor neoantigens. The company is headquartered in Framingham, Massachusetts.
Fundamentals
| Revenue (TTM) | $3.19M |
| Gross Profit (TTM) | $3.19M |
| EBITDA | $-5.75M |
| Operating Margin | -62.20% |
| Return on Equity | -37.00% |
| Return on Assets | -21.80% |
| Revenue/Share (TTM) | $1.69 |
| Book Value | $3.23 |
| Price-to-Book | 0.99 |
| Price-to-Sales (TTM) | 2.30 |
| EV/Revenue | 0.161 |
| EV/EBITDA | 1.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 36.00% |
| Shares Outstanding | $2.29M |
| Float | $1.78M |
| % Insiders | 15.77% |
| % Institutions | 7.38% |
Historical Volatility
HV 10-Day
73.95%
HV 20-Day
57.51%
HV 30-Day
53.73%
HV 60-Day
58.71%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026